Opendata, web and dolomites

EXCELLtoINNOV SIGNED

Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EXCELLtoINNOV" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://imm.medicina.ulisboa.pt/pt/imm-lisboa/projectos-internacionais/excelltoinnov/
 Total cost 2˙777˙183 €
 EC max contribution 2˙499˙465 € (90%)
 Programme 1. H2020-EU.4.c. (Establishing ‚ERA Chairs')
 Code Call H2020-WIDESPREAD-2014-2
 Funding Scheme CSA
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 2˙499˙465.00

Map

 Project objective

EXCELLtoINNOV will provide IMM with the needed means to achieve excellence on a sustainable basis through the recruitment of an ERA Chair in translational biomedical research in immunity and infection. This goal will be strategically achieved by placing IMM in the forefront of Research, Development and Innovation (R&DI) in immunity and infection, through the establishment of a translational biomedical research hub anchored in Lisbon that will: i. leverage the national potential beyond borders; ii. act as the interface of Europe with America and Africa; iii. and effectively contribute to overcome the health and demographic change societal challenges by potentiating major scientific advancements in this research area through worldwide collaborative efforts. The successful implementation of this strategy will be possible through specific activities, including: 1) the development of a new research field at IMM by the ERA Chair holder, pre-clinical molecular and imaging studies, that will transversally benefit and impact all research areas at IMM; 2) the implementation of structural changes at IMM to successfully support and comply with ERA priorities; 3) the expansion of overseas collaborations in international collaborative R&DI projects; and 4) an improved integration of IMM in the regional, national and international business community. Through the completion of these activities we will achieve an improved capability to compete successfully for internationally competitive research funding, including but not limited to Horizon 2020, IMI2 and EDCTP2 as well as effectively contribute to the objectives of regional smart specialisation strategies through increased international attractiveness, competitiveness and innovation potential of IMM, Lisbon and Portugal.

 Deliverables

List of deliverables.
Organisation of thematic Workshops – second period Documents, reports 2020-04-07 19:51:59
Publications in the research field of immunity and infection of the Instituto de Medicina Molecular Documents, reports 2020-04-07 19:51:59
Brochure and flyer development Websites, patent fillings, videos etc. 2020-04-07 19:51:59
Development of the project logo/brand Websites, patent fillings, videos etc. 2020-04-07 19:51:59
Organisation of thematic Workshops – first period Documents, reports 2020-04-07 19:51:59
Launch of website Websites, patent fillings, videos etc. 2020-04-07 19:51:59
Acquisition of the pre-clinical molecular and imaging equipment Documents, reports 2020-04-07 19:51:59
Forum for overseas discussion in translational immunity and infection Websites, patent fillings, videos etc. 2020-04-07 19:51:59

Take a look to the deliverables list in detail:  detailed list of EXCELLtoINNOV deliverables.

 Publications

year authors and title journal last update
List of publications.
2017 Marc Veldhoen
Interleukin 17 is a chief orchestrator of immunity
published pages: 612-621, ISSN: 1529-2908, DOI: 10.1038/ni.3742
Nature Immunology 18/6 2020-04-07
2017 Å pela Konjar, Cristina Ferreira, Birte Blankenhaus, Marc Veldhoen
Intestinal Barrier Interactions with Specialized CD8 T Cells
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01281
Frontiers in Immunology 8 2020-04-07
2018 Å pela Konjar, Birte Blankenhaus, Marc Veldhoen
Oxygen starvation during T cell priming boosts cancer-killing potential
published pages: S34-S37, ISSN: 2218-676X, DOI: 10.21037/tcr.2017.12.07
Translational Cancer Research 7/S1 2020-04-07
2018 Marc Veldhoen, Birte Blankenhaus, Å pela Konjar, Cristina Ferreira
Metabolic wiring of murine T cell and intraepithelial lymphocyte maintenance and activation
published pages: , ISSN: 0014-2980, DOI: 10.1002/eji.201646745
European Journal of Immunology 2020-04-07
2017 Verena Brucklacher-Waldert, Cristina Ferreira, Marisa Stebegg, Olivier Fesneau, Silvia Innocentin, Julien C. Marie, Marc Veldhoen
Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation
published pages: 2357-2370, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2017.05.052
Cell Reports 19/11 2020-04-07

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXCELLTOINNOV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXCELLTOINNOV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.4.c.)

R-Exposome Chair (2019)

R-Exposome Chair: Unlocking the potential of RECETOX in Exposome research

Read More  

NANOPLANT (2019)

The creation of the Department of Plant Nanotechnology to maximise the impact of the ERA Chair culture on the IPG PAS

Read More  

Chaperon (2019)

ERA Chair Position for Excellent Research in Oncology

Read More